• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿T细胞与常染色体显性多囊肾病的肾功能丧失率相关。

Urinary T cells correlate with rate of renal function loss in autosomal dominant polycystic kidney disease.

作者信息

Zimmerman Kurt A, Gonzalez Nancy M, Chumley Phillip, Chacana Teresa, Harrington Laurie E, Yoder Bradley K, Mrug Michal

机构信息

Department of Cell, Developmental and Integrative Biology, The University of Alabama at Birmingham, Birmingham, Alabama.

Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama.

出版信息

Physiol Rep. 2019 Jan;7(1):e13951. doi: 10.14814/phy2.13951.

DOI:10.14814/phy2.13951
PMID:30632307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6328912/
Abstract

Several innate immune response components were recognized as outcome predictors in autosomal dominant polycystic kidney disease (ADPKD) and their causative role in disease pathogenesis was confirmed in animal models. In contrast, the role of adaptive immunity in ADPKD remains relatively unexplored. Therefore, we evaluated T cell populations in kidney and urine of ADPKD patients using flow cytometry and confocal immunofluorescence microscopy approaches. These analyses revealed ADPKD-associated overall increases in the number of intrarenal CD4 and CD8 T cells that were associated with a loss of polarity in distribution between the cortex and medulla (higher in medulla vs. cortex in controls). Also, the urinary T cell-based index correlated moderately with renal function decline in a small cohort of ADPKD patients. Together, these data suggest that similar to innate immune responses, T cells participate in ADPKD pathogenesis. They also point to urinary T cells as a novel candidate marker of the disease activity in ADPKD.

摘要

几种先天性免疫反应成分被认为是常染色体显性多囊肾病(ADPKD)的预后预测指标,并且它们在疾病发病机制中的致病作用在动物模型中得到了证实。相比之下,适应性免疫在ADPKD中的作用仍相对未被探索。因此,我们使用流式细胞术和共聚焦免疫荧光显微镜方法评估了ADPKD患者肾脏和尿液中的T细胞群体。这些分析显示,ADPKD患者肾内CD4和CD8 T细胞数量总体增加,且与皮质和髓质之间分布极性丧失有关(与对照组相比,髓质中的数量高于皮质)。此外,在一小群ADPKD患者中,基于尿液T细胞的指标与肾功能下降呈中度相关。总之,这些数据表明,与先天性免疫反应类似,T细胞参与了ADPKD的发病机制。它们还指出尿液T细胞是ADPKD疾病活动的一种新型候选标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f85b/6328912/3afc1ff43f52/PHY2-7-e13951-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f85b/6328912/f202e33f638e/PHY2-7-e13951-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f85b/6328912/aa85d8006fa7/PHY2-7-e13951-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f85b/6328912/ce95ede2a752/PHY2-7-e13951-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f85b/6328912/16d88a1950d2/PHY2-7-e13951-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f85b/6328912/869adb2210d9/PHY2-7-e13951-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f85b/6328912/3afc1ff43f52/PHY2-7-e13951-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f85b/6328912/f202e33f638e/PHY2-7-e13951-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f85b/6328912/aa85d8006fa7/PHY2-7-e13951-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f85b/6328912/ce95ede2a752/PHY2-7-e13951-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f85b/6328912/16d88a1950d2/PHY2-7-e13951-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f85b/6328912/869adb2210d9/PHY2-7-e13951-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f85b/6328912/3afc1ff43f52/PHY2-7-e13951-g006.jpg

相似文献

1
Urinary T cells correlate with rate of renal function loss in autosomal dominant polycystic kidney disease.尿T细胞与常染色体显性多囊肾病的肾功能丧失率相关。
Physiol Rep. 2019 Jan;7(1):e13951. doi: 10.14814/phy2.13951.
2
CD8 T cells modulate autosomal dominant polycystic kidney disease progression.CD8 T 细胞调节常染色体显性多囊肾病的进展。
Kidney Int. 2018 Dec;94(6):1127-1140. doi: 10.1016/j.kint.2018.06.025. Epub 2018 Sep 21.
3
Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.尿血管紧张素原除影像学分类外,还可预测常染色体显性遗传性多囊肾病的肾脏结局。
J Korean Med Sci. 2020 Jun 8;35(22):e165. doi: 10.3346/jkms.2020.35.e165.
4
Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.常染色体显性多囊肾病中尿内皮素-1与估计肾小球滤过率的关系:一项初步横断面分析
BMC Nephrol. 2016 Feb 29;17:22. doi: 10.1186/s12882-016-0232-8.
5
Urinary biomarkers at early ADPKD disease stage.成人多囊肾病疾病早期的尿液生物标志物。
PLoS One. 2015 Apr 13;10(4):e0123555. doi: 10.1371/journal.pone.0123555. eCollection 2015.
6
Urinary renin-angiotensin markers in polycystic kidney disease.多囊肾病中的尿肾素-血管紧张素标志物
Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F874-F881. doi: 10.1152/ajprenal.00209.2017. Epub 2017 Jul 26.
7
Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.在常染色体显性遗传性多囊肾病患者中,尿血管紧张素原/肌酐(AGT/Cr)比值升高可能与肾功能降低有关。
BMC Nephrol. 2015 Jun 20;16:86. doi: 10.1186/s12882-015-0075-8.
8
Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.常染色体显性遗传多囊肾病的快速进展:尿液生物标志物作为预测指标。
Am J Nephrol. 2019;50(5):375-385. doi: 10.1159/000502999. Epub 2019 Oct 10.
9
Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).精氨酸加压素替代标志物尿 copeptin 与常染色体显性多囊肾病(ADPKD)严重程度的关联。
Clin Exp Nephrol. 2015 Dec;19(6):1199-205. doi: 10.1007/s10157-015-1101-7. Epub 2015 Feb 27.
10
Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression.尿胎球蛋白A是常染色体显性多囊肾病进展的生物标志物。
J Transl Med. 2015 Mar 30;13:103. doi: 10.1186/s12967-015-0463-7.

引用本文的文献

1
Autosomal Dominant Polycystic Kidney Disease Inflammation Biomarkers in the Tolvaptan Era.托伐普坦时代常染色体显性多囊肾病的炎症生物标志物
Int J Mol Sci. 2025 Jan 28;26(3):1121. doi: 10.3390/ijms26031121.
2
The impact of maternal obesity on polycystic kidney disease progression in a mouse model.母体肥胖对小鼠模型中多囊肾病进展的影响。
Am J Physiol Renal Physiol. 2025 Mar 1;328(3):F316-F327. doi: 10.1152/ajprenal.00227.2024. Epub 2025 Feb 5.
3
Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers.

本文引用的文献

1
CD8 T cells modulate autosomal dominant polycystic kidney disease progression.CD8 T 细胞调节常染色体显性多囊肾病的进展。
Kidney Int. 2018 Dec;94(6):1127-1140. doi: 10.1016/j.kint.2018.06.025. Epub 2018 Sep 21.
2
Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014).澳大利亚和新西兰多囊肾病所致终末期肾病的发病率及生存率(1963 - 2014年)
Popul Health Metr. 2017 Feb 17;15(1):7. doi: 10.1186/s12963-017-0123-7.
3
The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers.
预测常染色体显性多囊肾病的进展:对有前景的血清和尿液生物标志物的综述
Front Pediatr. 2023 Nov 10;11:1274435. doi: 10.3389/fped.2023.1274435. eCollection 2023.
4
Immune checkpoint activity regulates polycystic kidney disease progression.免疫检查点活性调节多囊肾病的进展。
JCI Insight. 2023 Jun 22;8(12):e161318. doi: 10.1172/jci.insight.161318.
5
Elevated checkpoint inhibitor expression and Treg cell number in autosomal dominant polycystic kidney disease and their correlation with disease parameters and hypertension.常染色体显性多囊肾病中检查点抑制剂表达升高及调节性T细胞数量增多及其与疾病参数和高血压的相关性
Clin Exp Med. 2023 Nov;23(7):3631-3640. doi: 10.1007/s10238-023-01031-2. Epub 2023 Mar 4.
6
A kidney resident macrophage subset is a candidate biomarker for renal cystic disease in preclinical models.肾脏固有巨噬细胞亚群是临床前模型中肾脏囊性疾病的候选生物标志物。
Dis Model Mech. 2023 Jan 1;16(1). doi: 10.1242/dmm.049810. Epub 2023 Jan 16.
7
The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression.色氨酸代谢酶吲哚胺 2,3-双加氧酶 1 调节多囊肾病的进展。
JCI Insight. 2023 Jan 10;8(1):e154773. doi: 10.1172/jci.insight.154773.
8
Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease.肌成纤维细胞耗竭可减少常染色体显性多囊肾病的肾囊肿生长和纤维化。
Kidney Int. 2023 Jan;103(1):144-155. doi: 10.1016/j.kint.2022.08.036. Epub 2022 Oct 20.
9
T-cell receptor αβ double-negative T cells in the kidney are predominantly extravascular and increase in abundance in response to ischemia-reperfusion injury.肾脏中 T 细胞受体 αβ 双阴性 T 细胞主要位于血管外,并且在缺血再灌注损伤时增加。
Immunol Cell Biol. 2023 Jan;101(1):49-64. doi: 10.1111/imcb.12595. Epub 2022 Oct 31.
10
Insights Into the Molecular Mechanisms of Polycystic Kidney Diseases.多囊肾病分子机制的见解
Front Physiol. 2021 Sep 8;12:693130. doi: 10.3389/fphys.2021.693130. eCollection 2021.
狼疮性肾炎中尿液免疫细胞的细胞特征:对潜在生物标志物的新见解
Arthritis Res Ther. 2015 Apr 3;17(1):94. doi: 10.1186/s13075-015-0600-y.
4
A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.超声与磁共振成像的比较表明,在常染色体显性多囊肾病中,肾脏长度可预测慢性肾病。
Kidney Int. 2015 Jul;88(1):146-51. doi: 10.1038/ki.2015.71. Epub 2015 Apr 1.
5
Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.来自 ERA-EDTA 注册处的数据分析表明,针对常染色体显性遗传性多囊肾病的常规治疗并不能减少肾脏替代疗法的需求。
Kidney Int. 2014 Dec;86(6):1244-52. doi: 10.1038/ki.2014.120. Epub 2014 May 14.
6
Renal macrophages in autosomal recessive polycystic kidney disease.常染色体隐性多囊肾病中的肾巨噬细胞
Nephrology (Carlton). 2013 Nov;18(11):746. doi: 10.1111/nep.12153.
7
Macrophages promote polycystic kidney disease progression.巨噬细胞促进多囊肾病的进展。
Kidney Int. 2013 May;83(5):855-64. doi: 10.1038/ki.2012.446. Epub 2013 Feb 20.
8
Macrophages promote cyst growth in polycystic kidney disease.巨噬细胞促进多囊肾病囊肿生长。
J Am Soc Nephrol. 2011 Oct;22(10):1809-14. doi: 10.1681/ASN.2011010084. Epub 2011 Sep 15.
9
Renal CD14 expression correlates with the progression of cystic kidney disease.肾组织 CD14 表达与囊性肾病的进展相关。
Kidney Int. 2010 Sep;78(6):550-60. doi: 10.1038/ki.2010.175. Epub 2010 Jun 16.
10
CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients.CXCR3+CD4+ T细胞在炎症性肾脏和尿液中富集,为系统性红斑狼疮患者的急性肾炎发作提供了一种新的生物标志物。
Arthritis Rheum. 2009 Jan;60(1):199-206. doi: 10.1002/art.24136.